← Open Payments lookup

PATRICK DISPOTO: Open Payments

NPI 1659815710 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,911 in 141 payments from 14 companies in 2025. Trend: 2023 $962 · 2024 $1,686 · 2025 $1,911

Food & beverage: $1,911
CompanyPaymentsAmount
Alkermes, Inc.14$270
Neurocrine BioSciences, Inc.19$267
Otsuka America Pharmaceutical, Inc.15$212
Vanda Pharmaceuticals Inc.11$207
E.R. Squibb & Sons, L.L.C.13$178
ABBVIE INC.32$153
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$135
Teva Pharmaceuticals USA, Inc.8$135
Janssen Pharmaceuticals, Inc6$105
Supernus Pharmaceuticals, Inc.5$77

Products named: INGREZZA, REXULTI, ARISTADA, COBENFY, VRAYLAR, FANAPT, CAPLYTA, INVEGA SUSTENNA.

Industry payments across NJ — which companies pay providers there.